Brief: Oryzon Receives “Intention To Grant” Communication For Patent Relating To Use Of Vafidemstat In Borderline Personality Disorder
Sept 11 (Reuters) - Oryzon Genomics SA ORY.MC :
* ORYZON RECEIVES “INTENTION TO GRANT” COMMUNICATION FOR
PATENT
RELATING TO THE USE OF VAFIDEMSTAT IN BORDERLINE PERSONALITY
DISORDER
Source text for Eikon: ID:nGNX9DHTwP
Further company coverage: ORY.MC
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ORYZON Genomics SA
See all newsBrief: Oryzon Gets New Patent Grants For Vafidemstat In Four Countries
Brief: Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment
Spanish stocks - Factors to watch on Aug 31
Brief: Oryzon Gets U.S. Patent Allowance For Iadademstat And Gilteritinib Drug Combo Application
Spanish stocks - Factors to watch on July 28